Back to Journals » Infection and Drug Resistance » Volume 12

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

Total article views   HTML views PDF downloads Totals
7,869 Dovepress* 7,318+ 1,665 8,983
PubMed Central* 551 216 767
Totals 7,869 1,881 9,750
*Since 1 April 2019

View citations on PubMed Central and Google Scholar